Tabrecta: Side Effects & Dosing

Tabrecta

Basic Prescribing Info

Contents

Capmatinib

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX17 - capmatinib ; Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Already a member? Sign In